City

Overall Status

Withdrawn (1)

Sign in for free

Phase

phase 1/phase 2 (1)

Sponsor

Rain Oncology Inc (1)

Collaborator

Intervention

atezolizumab (1)

milademetan (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

cdkn2a

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced Solid Tumor, CDKN2A, NSCLC Trial (Milademetan, Atezolizumab)

Withdrawn

Advanced Solid Tumor
+9 more

(no location specified)

Oct 16, 2023